Stephen Chia
BC Cancer Agency(CA)Canadian Cancer Society(CA)Benue State University(NG)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics
Most-Cited Works
- → Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer(2009)2,199 cited
- → The clonal and mutational evolution spectrum of primary triple-negative breast cancers(2012)2,008 cited
- → Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)(2013)1,241 cited
- → Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype(2008)1,187 cited
- → Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution(2014)633 cited
- → Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial(2017)580 cited